Following axotomy, a complex temporal and spatial coordination of molecular events enables regeneration of the peripheral nerve. In contrast, multiple intrinsic and extrinsic factors contribute to the general failure of axonal regeneration in the central nervous system. In this review, we examine the current understanding of differences in protein expression and post-translational modifications, activation of signaling networks, and environmental cues that may underlie the divergent regenerative capacity of central and peripheral axons. We also highlight key experimental strategies to enhance axonal regeneration via modulation of intraneuronal signaling networks and the extracellular milieu. Finally, we explore potential applications of proteomics to fill gaps in the current understanding of molecular mechanisms underlying regeneration, and to provide insight into the development of more effective approaches to promote axonal regeneration following injury to the nervous system.
Introduction
During development, neurons extend axons throughout the nervous system, establishing connections with post-synaptic targets that are often located quite long distances away from their origin. The ability of these young neurons to robustly extend their axons is dramatically diminished in adulthood, and this reduced intrinsic growth capacity is a key synaptotagmin, syntaxin, and synaptobrevin (19) . Following this initial burst of events, the soma undergoes chromatolysis, in which chromatin within the nucleus is dissipated and spread to the cell periphery as the cell body undergoes swelling. Excitatory inputs are mostly eliminated, leaving inhibitory inputs as the main communicators to the injured soma. This "synaptic stripping" is thought to involve glial cells and may prevent glutamate excitotoxicity (20) . with plus-end out orientation in the axon, these vesicles remain trapped at the growth cone, allowing for growth cone reconstruction.
The newly formed growth cone begins to recycle material thereby generating an immediate supply, but local protein synthesis is ultimately necessary for growth cone formation (31). Synthesis of proteins within the injured axon is a crucial event underlying regeneration, and improper regulation of this process can cause growth deficits (32).
Translation machinery and mRNAs are transported into the injured axon from the soma (33). Schwann cells have also been shown to transfer polyribosomes to the axoplasm of desomatized axons, suggesting that Schwann cells can modify protein expression of injured axons (34, 35).
After growth cone formation, injured axons start to regenerate or sprout. Earlier studies have indicated that axonal regeneration or sprouting is accompanied by activation of genes associated with developmental axon growth (36-38). Indeed, neurite outgrowth has been correlated with the ability to express regeneration-associated genes that are normally expressed during development (39); though there are distinctive regeneration programs associated with different modes of growth. Without a conditioning lesion, the dorsal root ganglion (DRG) neuron extends highly arborized neurites for a discrete period, a process that is dependent on new transcription. Within 24 hours, this growth switches to elongation growth in which fewer, longer axons extend from the soma (40).
In contrast, following a conditioning lesion, DRG neurons only exhibit elongation growth, which is dependent on translation for the formation of regenerating axons (41).
Together, these findings demonstrate that different modes of growth are associated with different patterns of protein expression. Key studies have revealed the importance of coordinated regulation of protein expression through the activation of specific signaling networks during axonal outgrowth and regeneration (see table 1 ). This emphasizes a potential for combined manipulation of multiple signaling pathways to activate robust regeneration programs. Indeed, there is a need to more fully understand the interactions between protein networks, and how these interactions impact axon growth and regeneration. 
II. Contribution of proteomic studies to axon regeneration

III. Importance of proteomics in identifying mechanisms involved in regeneration
Alterations in protein expression drive metabolic changes necessary for supported axonal growth. The cell's ability to activate these transcriptional and translational switches may account for the marked differences in regeneration observed in different classes of neurons. Following a peripheral injury to an axon in the sciatic nerve, regeneration is successful and neuromuscular junctions become re-innervated. However, injury to the central branch of a DRG axon root results in no regeneration (63) . However, the central branch of a DRG axon can successfully regenerate if its peripheral branch was first crushed days earlier (64, 65) . This is known as the conditioning effect. These observations indicate that the intrinsic state of a neuron can readily alter its regenerative ability. This difference in growth capacity has been associated with signaling pathways activated after peripheral nerve injury and relies on the coordinated expression of proteins in the axons and their somata (32, 41, 48, 66).
Successful peripheral regeneration and failure of central regeneration
The failure of axonal regeneration in the CNS is partially attributed to the proteome profile of the CNS, especially the extracellular milieu surrounding the injured adult axons (figure 1). The lesion site forms cystic or trabeculated cavities to which axons are unable to attach for growth (67) . These inhibitors fall into two classes: inhibitory molecules of the extracellular matrix (ECM), and inhibitory proteins associated with adult myelin.
After SCI, reactive macrophages, oligodendrocyte precursor cells, and reactive astrocytes shift the nature of the ECM at the lesion site, releasing cytokines, myelin associated inhibitors and chondroitin sulfate proteoglycan (CSPG) molecules that potently inhibit neurite growth (68) (69) (70) . These inhibitory molecules are not present within the peripheral nervous system, where axon regeneration robustly occurs after injury.
A second distinction between peripheral and central axons is microtubule stabilization.
Following injury, most mammalian CNS axons retract, and only a few axons sprout for short distances. These axons exhibit dystrophic, swollen endings where axons are exposed to an inhibitory environment. They fail to initiate growth cones, leading to failure to regenerate (71) . Recent studies demonstrate that retraction bulbs in the CNS have a disorganized microtubule network, whereas growth cones in the PNS contain organized bundling of microtubules (26). In addition, disruption of microtubules in growth cones using pharmacological agents transforms them into retraction bulb-like structures. Hence, microtubule stabilization prevents the formation of retraction bulbs and enhances the growth capacity of CNS neurons both in vitro and in vivo (72) .
A third mechanism that may influence regeneration is a potential lack of the localization of ribosomes and mRNAs in CNS axons. Local protein synthesis and mRNA localization has been closely associated with successful peripheral nerve regeneration (73) . Ribosomes actively translate proteins at the peripheral injury site that both propagate signals back to the soma and supply building blocks for new growth cone formation (31, 33, 74).
Equivalent mechanisms have not been extensively reported in the CNS, and we remain unaware of their potential contribution to CNS axon regeneration (75) . A mere lack of these local mechanisms in the injured axon tip could limit the cell's ability to successfully regenerate in the CNS, and the adequacy of this local response requires further study. 
Signaling networks associated with regeneration
Several signaling pathways have been shown to play a role in outgrowth after injury. For example, both the PI3K and ERK pathways are essential for axon assembly (84). When inhibitors to both pathways were applied to the axon compartment, axon extension was abolished (84).
The PI3K pathway has been linked to neurotrophin-induced axonal branching where axon turning towards an NGF gradient is PI3K dependent (85, 86). PI3K-Akt regulates local protein synthesis in the axon through the mTOR pathway, where adult CNS neurons require mTOR signaling for axon regeneration (31, 87, 88). Quantitative mass spectrometry identified syntaxin13 as a protein locally synthesized by activated mTOR in the axon (89) . Knockdown of syntaxin13 in culture prevented axon growth and regeneration. Interestingly, within the regenerating axon, PI3K is only activated at the distal tip, and its signaling is conveyed downstream through the inactivation of glycogen synthase kinase 3β (GSK3β) (90) , (91) . In adult DRG neurons, GSK3β inhibition leads to enhanced neurite outgrowth (92) . In hippocampal neurons, inactivation of GSK3β is crucial for axon specification and growth through the phosphorylation of CRMP-2 (93) (94) (95) . In cerebellar granule neurons, GRMP-2 is localized to dendritic branches, where its phosphorylation by GSK3β inhibits dendritic growth (96) .
GSK3β is widely expressed within the adult brain and is regulated through Akt as well as ILK, and PKC (97) (98) (99) . Inactivation of GSK3β stimulates axon elongation on inhibitory substrates in adult neurons, and induced corticospinal axon sprouting after injury (100).
Slit2 signaling inhibits neurite outgrowth through GSK3β phosphorylation in adult DRG neurons (101) . Therefore, GSK3β has been negatively linked to axon growth and sprouting. The role of GSK3β in axon growth is however controversial (102) .
Interestingly, GSK3β phosphorylation of MAP1B acts as a molecular switch to regulate microtubule dynamics in growing axons. Further, the MAPK pathway is involved in NGF mediated activation of TrkA, through phosphorylation of GSK3β during development (103) . Therefore, distinct molecular switches control developmental growth, which may be perceived as inhibitory in the adult neuron.
A few MAP kinases are involved in repair mechanisms (104, 105) . In dual leucine zipper kinase (DLK) knockout mice, neurons did not respond to a preconditioned lesion, suggesting this MAPKK kinase acts as a key mediator between the injured axon and somatic response to injury (106) . Extracellular signal regulated kinase (ERK)
phosphorylation is an essential component of the retrograde injury signal, and is thought to transmit information from the site of injury to the soma (107) . ERK is thought to regulate local protein translation after injury, and may play a role in axon outgrowth (108) . Growth cone collapse in response to semaphorin 3A is also regulated by ERK- STAT3 phosphorylation through gp130 signaling has also shown to increase regeneration after injury (117) , whereas phosphorylation of cytoplasmic set-β abolished its inhibitory role on neurite outgrowth (118) . Phosphorylation profiles in the injured cell have also been associated with inhibiting growth. The phosphorylation of Dock6, a guanine nucleotide exchange factor, inhibited its activity, which suppressed axon regeneration after injury in vitro and in vivo (119). Identifying key signaling networks associated with axon regeneration allows us to experimentally manipulate these pathways, unveiling potential therapies for regeneration.
Identification of post-translational modifications in the injured, degenerating, and regenerating environment
Post-translational modifications (PTMs) of proteins are also crucial modulators of the neuron's ability to respond to its environment. During glaucomatous neurodegeneration, Post-translational modifications play a critical role in the regulation of protein activity and biological signaling activity. Quantitative proteomics have the advantage to detect phospho-peptides, sumoylated-peptides, ubiquitinated-peptides, and palmitoylatedpeptides to name a few(134, 135). As more researchers employ these techniques, greater understanding of post-translational modifications related to disease will arise. At this juncture, combining high-throughput techniques and disease models will advance our understanding of spinal cord injury and help determine better therapeutic strategies (136).
IV. Experimental strategies to promote axonal regeneration
In order to identify therapeutic targets that can promote neural repair and functional recovery following CNS injury, it is important to understand neuron-intrinsic andextrinsic pathways underlying axonal regeneration (137).
Stimulating the endogenous growth state of the neuron
Experimental approaches to enhance neuron-intrinsic growth capacity have largely been informed by the study of molecular mechanisms active in regeneration-enabled neuronal populations. Here we review several studies in which key proteins have been identified in these populations and successfully manipulated to enhance axonal regeneration in models of CNS injury.
Intrinsic mechanisms of axon regeneration: The conditioning lesion
Enhanced spontaneous regeneration of PNS neurons is due to the activation of intrinsic signaling networks, in combination with a growth-permissive extrinsic environment, substantially enhances optic nerve regeneration.
Epigenetic mechanisms of axon regeneration
As epigenetic regulation of gene expression becomes more fully understood, the prospect that the epigenetic state of the neuron might significantly influence its intrinsic growth capacity becomes more compelling (168, 169) . In the last few years, experimental manipulation of chromatin dynamics in injury models has provided valuable insight into epigenetic influence on axon regeneration. 
Modifying the injured environment
The injured, adult CNS axon is faced with an extracellular milieu very different from that of the developing CNS and the PNS. The increased permissiveness of the peripheral nerve environment first gained appreciation from early studies demonstrating robust regeneration of central axons into grafted peripheral nerve "bridges" following CNS injury (182) . In subsequent decades, a plethora of work has identified specific components of the CNS environment that inhibit regeneration of central axons. Here we will briefly highlight key efforts to shape the injured CNS environment in order to enhance regeneration.
Myelin-associated inhibitors
Myelin-associated inhibitors are a group of proteins that inhibit regeneration of injured adult axons within the CNS ( figure 1) (5, 183) . The classical myelin-associated inhibitors, Nogo(184), OMgp (185) , and MAG(186), bind to transmembrane receptors on the axon(187-189), which modulates axon growth. We have also identified netrin-1 as a novel Myelin-associated inhibitor in the spinal cord (190) . Though experimental deletions of these myelin-associated inhibitors or their receptors have thus far shown a limited effect on axonal regeneration (183), it is clear that OMgp and Nogo modulate axon sprouting following SCI (191) .
Neutralizing the inhibitory ECM
Following injury to the CNS, the lesion site becomes surrounded by reactive scar tissue, and axons interacting with this glial scar form dystrophic end bulbs and fail to regenerate; this process is reviewed in detail elsewhere (6, (192) (193) (194) . Chondroitin sulfate proteoglycans (CSPGs), a class of proteins with sulfated glycosaminoglycan (CS-GAG) moieties, are deposited by macrophages, microglia and reactive astroglia, and encompass a major component of this inhibitory environment from very early to chronic stages after injury (195) . Though the inhibitory nature of these proteins has long been appreciated, the axonal receptors that bind them have only recently begun to be identified. One of these, receptor protein tyrosine phosphatase sigma (PTPσ), has been successfully targeted in experimental studies to promote axon regeneration in the optic nerve (196) and the spinal cord (197, 198) . Notably, Silver and colleagues successfully promoted regeneration of serotonergic projections and enhanced functional recovery via systemic delivery of a mimetic peptide, presenting an attractive strategy for potential clinical translation. The
Nogo receptors NgR1 and NgR3 were also identified as CSPG receptors by Giger's group, who demonstrated significant regeneration of injured optic nerve axons in NgR1
-/-and NgR3 -/-animals (199) .
Aside from inhibiting the activity of CSPG receptors, others have utilized the enzyme chondroitinase ABC (ChABC) to degrade CS-GAG moieties from CSPGs, rendering the scar environment less inhibitory to axon growth (200) . These efforts have led to several reports of improved axon growth and, in some cases, functional gains in models of partial rodent spinal cord injury (195, (201) (202) (203) (204) .
Providing permissive substrates for CNS axon regeneration
Strategies to modulate the extrinsic environment to promote regeneration are not limited to the neutralization of inhibitory factors. Recent work from our group has demonstrated the powerful potential of transplanting permissive neural stem cells (NSCs) into the lesioned spinal cord to promote host axonal regeneration (205, 206) . Following neural stem cell transplantation into sites of severe SCI, we observed that injured supraspinal host axons penetrated grafts for distances up to 2 mm, and formed synaptic connections with grafted neurons. Moreover, these grafts placed in sites of SCI attenuate the reactive glial scar surrounding the lesion (205) . Though the molecular mechanisms supporting CNS axon regeneration into permissive neural stem cell grafts are just beginning to be explored, it is plausible that grafted cells provide a combination of trophic support for regeneration as well as permissive extracellular matrix and/or cell adhesion molecules that attract host axonal regeneration and synapse formation with graft-derived neurons.
Ongoing work in our laboratory is focused on characterizing the molecular factors in these permissive cell grafts that support regeneration of host axons. These findings have opened the door to a promising new strategy to overcome the inhibitory extrinsic environment and provide new post-synaptic targets via the reconstitution of spinal cord tissue with neural stem cells.
Stimulating growth of the injured axon: Growth factors and diffusible factors
The success of peripheral nerve regeneration is attributed in part to the presence of neurotrophins secreted by Schwann cells in gradients that support regeneration throughout the peripheral nerve milieu (207, 208) . These proteins provide trophic support for peripheral neuron survival and axon growth; in contrast, trophic factors are not secreted in temporal and spatial gradients to enable regeneration in the adult injured CNS.
We will briefly summarize studies utilizing exogenous growth factor delivery to support regeneration of injured CNS populations.
Growth factor effects on spinal cord axon regeneration
Spinal cord axons can be induced to regenerate by the provision of appropriate gradients of neurotrophins delivered exogenously either by genetically modified growth factorsecreting cell grafts (209) . Early work from our group showed that NGF-expressing fibroblasts grafted into sites of acute and chronic SCI support extensive growth of central supraspinal and sensory axons, establishing that adult CNS axons retain the ability to regenerate if appropriate gradients of growth factors are provided (210, 211) .
Administration of NT-3 also promotes growth of injured sensory axons in vivo (212) (213) (214) (215) . Work by our group demonstrated the ability of NT-3 gradients to enable guidance and reinnervation of appropriate brainstem targets by lesioned, ascending sensory axons (216) . BDNF also promotes regeneration of multiple injured spinal cord projections, including rubrospinal (217, 218) and reticulospinal axons (219) . We observed growth of cerulospinal, serotonergic, CGRP+, and ChAT+ axons into BDNF-secreting MSC grafts, demonstrating that BDNF exerts trophic effects on multiple axon populations (220) .
Growth factor effects on the injured corticospinal projection
Efforts to elicit growth of injured corticospinal axons using neurotrophic factors have been largely unimpressive. An early study by our group showed the failure of brainderived neurotrophic factor (BDNF) to influence corticospinal axon growth even as BDNF supports survival of axotomized corticospinal neurons (221) ; however this may be because the BDNF receptor TrkB was not trafficked from the cell body into the axon.
Indeed, viral-mediated TrkB overexpression in the corticospinal soma enhanced regeneration of a modest number of corticospinal axons into BDNF-expressing grafts placed in a sub-cortical lesion, but not in sites of SCI (222) . Neurotrophin-3 (NT-3) also enhances corticospinal sprouting (223) , resulting in partial functional recovery after SCI (224) . In a primate spinal cord injury model, corticospinal axons also failed to penetrate grafts of BDNF/NT-3 secreting fibroblasts, although lesioned brainstem projections did regenerate in to the grafts (225) . Together, these findings demonstrate that provision of BDNF or NT-3 is not a sufficient strategy to promote regeneration of corticospinal axons;
rather, it is likely that more permissive substrates, such as neural stem cell transplant, in combination with intrinsic manipulations will be needed to achieve robust regeneration of this notoriously regeneration-deficient projection.
The role of neurotrophins in the injured optic nerve
It has been well documented that trophic factors promote the survival of retinal ganglion cells (RGCs) following optic nerve injury (226); however, the ability of growth factor treatment to support regeneration of retinal ganglion cell axons is less clear. Treatment with ciliary neurotrophic factor (CNTF) enhanced axonal regeneration after optic nerve injury into peripheral nerve grafts (227) . Viral delivery of CNTF to the RGC soma was also shown to increase survival of retinal ganglion cells after optic nerve injury, and to promote regeneration of injured axons for several millimeters (228, 229) . Belin, S., Nawabi, H., Wang, C., Tang, S., Latremoliere, A., Warren, P., Schorle, H., Uncu, C., Woolf, C. J., He, Z., and Steen, J. A. 
